Ratings The Chemours Company

Equities

CC

US1638511089

Real-time Estimate Cboe BZX Other stock markets 01:47:46 2024-04-24 pm EDT			5-day change	1st Jan Change
27.12 ^USD	+1.44%		+2.69%	-14.14%

Apr. 10	North American Morning Briefing : Traders Await -2-	DJ
Apr. 09	BMO Capital Upgrades Chemours to Outperform From Underperform, Raises Price Target to $34 From $19	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The company is one of the best yield companies with high dividend expectations.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company is in debt and has limited leeway for investment
The company appears highly valued given the size of its balance sheet.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
THE CHEMOURS COMPANY	-14.14%	3.98B	C+
SHIN-ETSU CHEMICAL CO., LTD.	+9.55%	80.03B	B
BASF SE	+5.21%	48.78B	A-
DUPONT DE NEMOURS, INC.	-4.43%	30.85B	C
PIDILITE INDUSTRIES LIMITED	+8.67%	17.8B	B
BRENNTAG SE	-8.60%	11.66B	B
EASTMAN CHEMICAL COMPANY	+7.27%	11.38B	A-
ASAHI KASEI CORPORATION	+3.37%	9.84B	A-
SYENSQO SA/NV	-8.79%	9.83B	-
SRF LIMITED	+5.46%	9.31B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes